Sanofi paid a more than 300% premium on its acquisition of Vigil Neuroscience, suggesting a fierce battle to seal the deal. Across biopharma, companies are sometimes willing to put it all on the line for the right buyout. Novartis’ recent acquisition of Regulus for $800 million upfront provides a case study.
Biopharma Deal Premiums Paint Picture of Cutthroat Negotiations Read More »
BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to bring to market any product to help in the fight against COVID-19.” Now, the mRNA biotech is buying that very company.
BioNTech Attacked CureVac’s ‘Failed’ COVID Vaccine Program. The Rivals Are Now Merging Read More »
Medicaid provisions in Republicans’ reconciliation megabill would lead to between 8,000 and nearly 25,000 medically preventable deaths, according to new research in the Annals of Internal Medicine.
GOP Medicaid cuts would cause thousands of preventable deaths: study Read More »
The deal, which is expected to close later this year, will add more than 250 ambulatory surgery centers across 34 states to Ascension’s portfolio.
Ascension agrees to acquire Amsurg to expand ambulatory surgery reach Read More »
Hospital groups slammed the Senate’s version of the GOP legislation. The upper chamber “made a bad bill worse,” said Chip Kahn, CEO of the Federation of American Hospitals.
Senate Republicans propose deeper Medicaid cuts in reconciliation bill Read More »
The program will bring together experts from across the FDA for a team-based review, rather than having an application move across numerous offices within the agency before getting a yay or nay.
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews Read More »
The robot maker, which is expanding globally, believes it can stand out in competition with market leader Intuitive Surgical with a technologically advanced system that is affordable and accessible.
SS Innovations’ robot used in its first cardiac surgery in Americas Read More »
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
Anne Wojcicki wins bid to buy back 23andMe for $305M Read More »
At the insurer’s investor day, Humana struck a middle ground in defending the importance of the privatized Medicare program — which accounts for the bulk of its revenue — while allowing that there’s room for improvement.
Humana’s cautious defense of the Medicare Advantage program Read More »
Una de las preguntas más fundamentales de la neurociencia es cómo el cerebro puede gestionar los recuerdos. Se cree que los recuerdos se almacenan mediante cambios biofísicos y moleculares en conjuntos neuronales llamados engramas, distribuidos en diferentes regiones cerebrales. …
La búsqueda de las huellas biofísicas de los recuerdos en el cerebro Read More »
